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This study was performed to investigate the genotypic causes of colistin resistance
in 18 colistin-resistant Klebsiella pneumoniae (n = 13), Escherichia coli (n = 3) and
Pseudomonas aeruginosa (n = 2) isolates from patients at the Hamad General
Hospital, Qatar. MIC testing for colistin was performed using Phoenix (BD Biosciences,
Heidelberg, Germany) and then verified with SensiTest Colistin (Liofilchem, Zona Ind.
le, Italy). Strains determined to be resistant (MIC > 4-16 µg/mL) were then whole-
genome sequenced (MiSeq, Illumina, Inc.). Sequences were processed and analysed
using BacPipe v1.2.6, a bacterial whole genome sequencing analysis pipeline. Known
chromosomal modifications were determined using CLC Genomics Workbench v.9.5.3
(CLCbio, Denmark). Two K. pneumoniae isolates (KPN-15 and KPN-19) harboured mcr-
8.1 on the IncFII(K) plasmids, pqKPN-15 and pqKPN-19, and belonged to ST383 and
ST716, respectively. One E. coli isolate harboured mcr-1.1 on the IncI2 plasmid pEC-
12. The other 15 isolates harboured known chromosomal mutations linked to colistin
resistance in the PhoPQ two-component system. Also, three K. pneumoniae strains
(KPN-9, KPN-10 and KPN-15) showed disruptions due to IS elements in mgrB. To our
knowledge, this marks the first description of mcr-8.1 in K. pneumoniae of human origin
in Qatar. Currently, more research is necessary to trace the source of mcr-8.1 and its
variants in humans in this region.
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INTRODUCTION
Resistance to colistin, a last-resort antibiotic, has been identified in humans, livestock animals,
and the environment (Forde et al., 2018). Colistin (polymyxin E) is a cationic polypeptide
synthesised from Paenibacillus polymyxa subspecies Colistinus (Poirel et al., 2017). Colistin was
first introduced for the treatment of GNB (Gram-negative bacteria) infections in 1952 and was used
until the 1980s; however, its use in human medicine was limited due to neuro and nephrotoxicity
(Akajagbor et al., 2013). Unfortunately, the emergence of multi and extensive drug resistance
pathogens has necessitated colistin’s reintroduction to clinical practice (Catchpole et al., 1997).
Colistin resistance is typically caused by chromosomally mediated modifications to its target site,
Frontiers in Microbiology | www.frontiersin.org 1 August 2020 | Volume 11 | Article 1954
fmicb-11-01954 August 24, 2020 Time: 11:32 # 2
Eltai et al. mcr-8 Identification in Qatar
the LPS (lipopolysaccharide) in the outer membrane of GNB,
thereby reducing its binding affinity (Poirel et al., 2015; Aghapour
et al., 2019). Colistin resistance was thought to have only a vertical
spread, but recently horizontally transmitted plasmid-mediated
resistance has emerged.
Colistin is a cationic molecule that interactions with the
negatively charged lipopolysaccharide present on the outer
membrane. This increases membrane permeability, eventually
leading to bacterial death (Poirel et al., 2015). Interestingly,
colistin resistance has been linked to higher levels of susceptibility
to other antimicrobial agents, due to the outer membrane
disruption enabling better passage of these into the cell. This
appears to be particularly true for hydrophobic antibiotics
(Li et al., 2020). Conversely, colistin resistance has also been
implicated in resistance to cationic antimicrobial peptides present
in the host. Studies have documented that mcr-1.1 can confer
resistance to the cationic lysozyme as well as other cationic host
antimicrobials (Napier et al., 2013; Sherman et al., 2016). This
presents a significant concern due to the potential of mcr genes
to be maintained due to the advantage they provide in surviving
host-microbial (Napier et al., 2013; Sherman et al., 2016).
Transferable resistance was first reported in China in 2015
as the mcr-1.1 gene, a phosphoethanolamine (pEtN) transferase
which adds pEtN to the lipid A moiety of the LPS, preventing
colistin binding through the reduction of the negative charge on
the LPS (Liu et al., 2016; Aghapour et al., 2019). Homologous
pEtN transferases were identified in Gram-negative bacteria, such
as mcr-2.1 from Belgian porcine E. coli (Xavier et al., 2016). Since
then, nine different mcr genes and several variants have been
identified across the globe (Carroll et al., 2019). In Qatar, mcr-
1.1 was first reported in 2018 in E. coli isolated from broiler
chickens and MDR E. coli from a patient with subarachnoid
haemorrhage (Eltai et al., 2017; Forde et al., 2018). Additionally,
studies have described mcr-1.1 from clinical isolates in Jordan
and mcr-5.1 present in human isolates in Saudi Arabia (Redhwan
et al., 2019). Mcr-8.1 has been previously reported in animal, and
human Klebsiella pneumoniae isolates from China and Laos, and
recently, Algeria, Morocco, France, Bangladesh, and Saudi Arabia
(Wang et al., 2018, 2019; Hadjadj et al., 2019; Bonnin et al.,
2020; Farzana et al., 2020; Hala et al., 2020; Nabti et al., 2020).
A recent review on colistin resistance in the Middle East reported
the presence of mcr genes in six countries in the region in
K. pneumoniae isolates (Aris et al., 2020). Interestingly, it is
reported that the majority of resistance is mediated by mgrB
mutations with few appearing to harbour plasmid-mediated
resistance. However, the proportion of resistance due to mcr gene
has been increasing since their discovery in 2015. This increase in
resistance has been suggested the use of antibiotics in the region
(Aris et al., 2020).
While primarily present in animal associated isolates mcr
genes are a typical example of the importance and necessity for
a One Health approach, with recent reports showing carriage of
mcr genes in both hospital and community-associated human
bacterial pathogens such as K. pneumoniae and Acinetobacter
spp. (Agaba et al., 2017). Therefore, surveillance of antimicrobial
resistance mandates the determination of the prevalence ofmcr in
human bacterial pathogens and an assessment of their impact on
clinical outcome. In this study, we analysed 18 isolates obtained
from patients admitted to the Hamad General Hospital (HGH)
in Qatar in order to determine the prevalence and identify the
underlying mechanisms leading to their colistin resistance.
MATERIALS AND METHODS
In total, 18 isolates belonging to K. pneumoniae (n = 13),
E. coli (n = 3) and Pseudomonas aeruginosa (n = 2) were
analysed in this study. Strain characteristics of the 18 isolates
are described in Table 1 and Supplementary Table S1. Species
confirmation was performed by MALDI-TOF (Bruker Daltonik
GmbH, Leipzig, Germany). Ethical approval (MRC-01-17-198)
was obtained from the Medical Research Centre (MRC),
Hamad Medical Corporation (HMC), Doha, Qatar. Initial
antimicrobial susceptibility testing was performed by Phoenix
using the NMIC/ID-5 panel (BD Biosciences, Heidelberg,
Germany) according to the manufacturer’s recommendations.
Briefly, panels were inoculated with 0.5 McFarland pure culture,
placed into the instrument and incubated at 35◦C. The
instrument tests panel every 20 min up to 16 h if necessary.
MIC values of each antimicrobial agent automatically read as
susceptible, intermediate, or resistant (SIR). Isolates showing
colistin resistance by Phoenix were consequently confirmed
using the SensiTest colistin kit (Liofilchem, Zona Ind. le, Italy),
following the manufacturer’s instructions. Briefly, a suspension
of 0.5 McFarland standard was prepared from the tested
organism, and then diluted 1:20 in saline. 0.4 ml of this
diluted suspension was added to a tube of Muller Hinton broth
provided in the kit (solution B). 100 µl of solution B was
dispensed to the seven wells in a row. Then the plate was
incubated at 36 ± 2◦C for 16-20 h. The lowest concentration
of antibiotic that inhibits visible growth was recorded and
interpreted according to Clinical and Laboratory Standards
Institute (CLSI) guidelines.
DNA Extraction and Sequencing
Genomic DNA was extracted from all isolates using a QIAamp R©
UCP Pathogen mini kit (Qiagen, Düsseldorf, Germany)
according to the manufacturer’s protocol. Briefly, from each
isolate’s genomic DNA was purified, and later quantified using a
Qubit dsDNA high sensitivity assay (Thermo Fisher, Waltham,
United States). Libraries were prepared using Nextera XT and
sequenced via (2 bp × 250 bp) v2 500 cycle, MiSeq (Illumina,
Inc., United States). The raw sequences were subjected to
a quality check and analysis using our in-house pipeline,
BacPipe v.1.2.6 (Xavier et al., 2020). Briefly, the reads were
quality assessed, trimmed, followed by de novo assembly
(SPAdes), typing (MLST), genome annotation (Prokka), and
resistance genes (ResFinder and CARD). The scaffolds were run
through Plasmid Finder (Carattoli et al., 2014) to determine
the incompatibility type of the plasmids. Insertion element (IS)
families were analysed through IS Finder (Siguier, 2006). Genetic
characterisation, chromosomal gene modifications and mcr gene
based phylogenetic analysis were done using CLC Genomics
workbench v9.5.3 (CLCbio, Denmark).

















TABLE 1 | Mutations present in isolates (n = 18) of K. pneumoniae (n = 13), E. coli (n = 3), and P. aeruginosa (n = 2) conferring resistance to colistin and other antimicrobials.
Strain ID Sample type DOI Organism ST Gene modifications leading
to colistin resistance




KPN-2 Wound August, 2018 K. pneumoniae ST792 PhoP L26Q NA >4 R 0.5 S Beta-lactam: blaSHV-26, Fosfomycin: fosA, Quinolone: oqxB, oqxA
KPN-3 Urine July, 2018 K. pneumoniae ST25 PhoP L26Q NA >4 R >16 R Beta-lactam: blaSHV-81, Fosfomycin: fosA, Quinolone: qnrS, oqxB, oqxA,
Macrolide: mph(A) Trimethoprim: dfra15, dfrA1 Phenicol: catA1











K. pneumoniae ST11 PhoP L26Q NA >4 R >16 R Beta-lactam: blaSHV-182, blaCTX-M-15, blaOXA-232, blaTEM-1B,
Fosfomycin: fosA, Quinolone: aac (6′)-Ib-cr, oqxA, oqxB Aminoglycoside:
rmtF, aph (3′)-Ib, aac(6′)-Ib3, aph(6)-Id Sulphonamide: sul2
KPN-9 Urine -
Catheter




NA >4 R >16 R Beta-lactam: blaSHV-28, blaOXA-1, blaOXA-232, Fosfomycin: fosA,
Quinolone: aac (6′)-Ib-cr, oqxA, oqxB, Macrolide: mph(E), msr(E),








NA >4 R 16 R Beta-lactam: blaTEM-1A, blaCTX-M015, blaSHV-28, blaOXA-1,
Fosfomycin: fosA, Quinolone: oqzA, oqxB, Macrolide: mph(E), msr(E),
Trimethoprim: dfrA12, dfrA1, dfrA14 Phenicol: catB3, Aminoglycoside:
aac(6′)-IB-cr, aadA, armA Sulphonamide: sul1 Tetracycline: tet(D)
KPN-14 Tissue November,
2016
K. pneumoniae ST383 PhoP L26Q, mgrB
L9*
NA >4 R >16 R Beta-lactam: bla)XA-48, blaCTX-M-14, blaSHV-26, Fosfomycin: fosA,
Quinolone: oqxB, oqxA, Macrolide: mph(A), msr(E), erm(B), Trimethoprim:






K. pneumoniae ST383 PhoP L26Q, mgrB
interruption at
118th base
mcr-8.1 >4 R >16 R Beta-lactam: blaSHV-26, Fosfomycin: fosA, Quinolone: oqxA, oqxB,




June, 2017 K. pneumoniae ST383 PhoP L26Q NA >4 R 8 R Beta-lactam: blaCTX-M-15, blaSHV-26, blaOXA-9, blaCTX-M-14b,
blaTEM-1B, blaNDM-5, blaOXA-48, Fosfomycin: fosA, Quinolone: qnrS1,
oqxB, oqxA, mph (E), aac (6′)-Ib-cr, msr(E), mph(A), Trimethoprim: dfrA5,
Phenicol: catA1, Aminoglycoside: aadA1, aph(3′)-Ia, aac(6′ ′)-Ib, aph(6)-Id,



































TABLE 1 | Continued
Strain ID Sample type DOI Organism ST Gene modifications leading
to colistin resistance




KPN-17 ETA August, 2017 K. pneumoniae ST231 PhoP L26Q NA >4 R 16 R Beta-lactam: blaTEM-Ib, blaCTX-M-015, blaOXA-232, Fosfomycin: fosA,
Quinolone: oqxB, oqxA, Macrolide: mph(A), erm(B), Trimethoprim: drfA12,
Phenicol: catA1, Aminoglycoside: aac (6′)-Ib3, aadA2, aac (6′)-Ib-cr,
qepA4, rmtF Sulphonamide: sul1, Tetracycline: tet(B), Rifampicin: ARR-3
KPN-18 Wound October,
2015
K. pneumoniae ST147 PhoP L26Q NA >4 R 16 R Beta-lactam: blaCTX-M-15, blaSHV-67, Fosfomycin: fosA, Quinolone:
aac(6′)-Ib-cr, oqxA, oqxB, qnrB1, Trimethoprim: dfrA12, Aminoglycoside:





K. pneumoniae ST716 PhoP L26Q mcr-8.1 >4 R 16 R Beta-lactam: blaTEM-Ib, blaCTX-M-15, blaSHV-27, blaOXA-1, Fosfomycin:
fosA, Quinolone: oqxA, oqxB, qnrB1, Macrolide: mph(A), Trimethoprim:
dfrA12, dfrA14, Phenicol: catB3, Aminoglycoside: aac(3)-Iia, aac(6′)-Ib-cr,




K. pneumoniae ST231 PhoP L26Q
Absence of mgrB
NA >4 R < 16 R Beta-lactam: blaTEM-iB, blaCTX-M-15, blaSHV-28, Fosfomycin: fosA,
Quinolone: oqxA, oqxB, Macrolide: mph(A), erm(B) Trimethoprim: dfrA12,




May, 2016 E. coli ST156 NA mcr-1.1 4 R 4 R Beta-lactam: blaCTX-M-55, blaTEM-1B, Fosfomycin: fosA, Quinolone:
qepA1, Macrolide: mph (E), mdf(A), Trimethoprim: dfraA17, Phenicol:
catA1, Aminoglycoside: aph (3′)-Ib, aadA5, aph(6)-Id, Sulphonamide: sul1,
sul2 Tetracycline: tet(A)




E. coli ST452 NA NA 4 R 4 R Macrolide: mdf(A)
PA-11 Sputum March, 2015 P. aeruginosa ST500 NA NA 4 I 2 S Beta-lactam: blaOXA-486, blaPAO, Fosfomycin: fosA, Quinolone: crpP,
Phenicol: catB7, Aminoglycoside: aph(3′)-IIb
PA-13 Bone tissue October,
2019
P. aeruginosa ST357 NA NA ≤1 X 4 R Beta-lactam: blaVEB-1, blaOXA-10, blaPAO, blaNDM-1, blaOXA-50,
Fosfomycin: fosA, Quinolone: crpP, Trimethoprim: dfrB2, Phenicol: catB7,
cmlA1, Aminoglycoside: aph(3′)-Iib, aadA1, aph(3′)-VI, ant(2′)-Ia, ac(6′)-II,
Sulphonamide: sul1, Tetracycline: tet(A)
All known colistin mutations are confirmed (Poirel et al., 2017). Strain types and genes conferring resistance to other antimicrobials were obtained through BacPipe. The MIC values were obtained using Phoenix and
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FIGURE 1 | Genetic organisation of pKPN-15 and pKPN-19 harbouring mcr-8.1 gene.
RESULTS
All isolates (n = 18) showed resistance to colistin with
MICs > 4 µg/mL in both Phoenix and SensiTest results, except
KPN-2 and EC-21 (Table 1). The clonal diversity among the
isolates was determined; the K. pneumoniae isolates had nine
different strain types (STs) (ST11, ST383, ST792, ST25, ST323,
ST231, ST147, ST716, and ST2096, the E. coli isolates had two
unique types (ST19, ST53), and one novel ST (Wirth et al., 2006),
and P. aeruginosa had two types (ST500, ST357) (Table 1).
TwoK. pneumoniae isolates (KPN-15 and KPN-19) harboured
mcr-8.1 (Figure 1), and one E. coli (EC-12) carried mcr-1.1. For
the mcr-8.1 harbouring strains, KPN-15 was found to have a MIC
of > 16 µg/mL and KPN-19 a value of 16 µg/mL when evaluated
using SensiTest. All other K. pneumoniae isolates had MIC values
of 16 or > 16 µg/mL (Table 1). EC-12 harboured mcr-1.1 and was
observed to have a MIC value by SensiTest of 4 µg/mL.
The contigs containing the mcr genes were analysed using
BLAST to determine their origin and genetic context (Figure 1).
Contig from isolate KPN-15 gave the top BLAST search hit
to plasmid pLH94-8 (CP035204) with an 81% coverage and
99.7% sequence identity. Similarly, contig from isolate KPN-
19, a top BLAST search hit was plasmid pLH94-8, with a
77% query coverage and 99.3% nucleotide identity. Isolates
KPN-15 and KPN-19 harboured plasmid types (IncFII(Yp)
and IncL) and IncFII(K), respectively. E. coli isolate EC-12
underwent the same analysis procedure as the K. pneumoniae
strains. Isolate EC-12 contained mcr-1.1 with the top BLAST
search hit being E. coli p1540-1 (CP019052) with 100%
query coverage and 99.9% sequence identity. PlasmidFinder
revealed the mcr-1.1 was harboured on plasmid type IncI2.
KPN-15 and KPN-19 containing mcr-8.1 as well as the
reference pLH94-8 were also examined for additional resistance
genes to other antimicrobial agents and genetic similarity.
The contigs containing the mcr-8.1 gene, harbours no other
resistance genes were identified for either KPN-15 or KPN-19.
However, it was found that all isolates harbours other resistance
genes such as beta-lactams, aminoglycoside, macrolides and
tetracycline (Table 1).
While only three isolates (KPN-15, KPN-19, and EC-12)
carried mcr genes, other genetic mutations that have been
previously associated with colistin resistance were observed
and are reported in Table 1. In particular, mutations in the
negative PhoPQ regulator mgrB, as well as in phoP, were the
main modifications in study isolates linked to colistin resistance.
K. pneumoniae isolates (KPN-9, KPN-10, KPN-14, and KPN-15)
had modifications in themgrB gene. Three of these isolates (KPN-
9, KPN-10, and KPN-15) had MIC values of > 16 µg/mL while
KPN-14 had a value of 16 µg/mL. KPN-9 and KPN-10 had the
gene disruption at position 74th nucleotide, while KPN-15 had
it at position 118th nucleotide. For KPN-9 it was determined
that ISKpn-26 mediated the disruption. No insertion element
could be found for KPN-10, and the change appeared to be
due to a frameshift mutation. For KPN-15, while the disruption
was mediated by IS1 family elements, the specific element could
not be determined. Isolate KPN-20 appeared to be lacking the
mgrB gene entirely, with only 10 bp remnants corresponding
to the gene being found. While there were multiple mutations
observed in the PhoPQ and PmrAB two-component systems in
our isolates, only the phoP L26Q mutation was linked to colistin
resistance. This mutation was present in all the K. pneumoniae
isolates (n = 13). The evolutionary relationship of mcr-8.1 were
compared with all other known mcr genes (1-10) and its variants.
The mcr-8.1 gene is closely related to mcr-4 and mcr-5 genes
(Supplementary Figure S1).
DISCUSSION
Clonal Diversity and Plasmid Types
The clonal diversity of the isolates showed that the majority
belonged to known clones. In particular, the ST for
K. pneumoniae mostly belonged to known epidemic clones
(ST147, ST11, ST231, ST792, ST383). For the isolates that
harboured mcr genes (KPN15, KPN-19, EC-12), the ST type
was examined to see if it had previously been linked to other
antimicrobial-resistant mechanisms. KPN-15 belonged to ST383;
a well-characterised ST known to harbour genes conferring
carbapenem resistance (Sabirova et al., 2016), while KPN-19
was ST716, a strain type that has been previously linked to
an outbreak of New-Delhi metallo-beta-lactamase resistant
K. pneumoniae (Heinrichs et al., 2019). EC-12 belonged to
ST156, reported previously in mcr-1.1 harbouring E. coli
in Brazil, and a carbapenemase carrying isolate in China
(Rossi et al., 2017).
The incompatibility types of the plasmids found in these
isolates harbouring mcr-8.1 or mcr-1.1 were searched in the
literature to look for previous reports of mcr carriage. The
presence of IncFII plasmids in KPN-15 and KPN-19 potential
source of origin harbouring mcr-8.1 gene variants has been
reported in previous studies (Wang et al., 2018, 2019; Hadjadj
et al., 2019; Wang et al., 2019). Similarly, the presence of IncI2 in
EC-12 is unsurprising as it is the first Inc type described with mcr-
1.1 and has been widely reported since then (Zurfluh et al., 2017).
mcr Genes
Studies have shown that mcr-1.1 confers low to moderate
level resistance (Cao et al., 2018), as seen in isolate EC-12
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which had a MIC value of 4 µg/mL. Previous studies on mcr-
8.1 have reported MIC values of 16 µg/mL (Wang et al.,
2018; Bonnin et al., 2020), however, for our study, we are
unable to conclude if our isolates demonstrate higher than
16 µg/mL as the SensiTest method can only delineate colistin
MICs up to 16 µg/mL. Nonetheless, all of the resistant
K. pneumoniae strains, whether or not they carried mcr-
8.1, had values of 16 µg/mL or > 16 µg/mL (Table 1).
Additionally, mutations to the PhoPQ system, such as the
L26Q phoP mutation seen in all K. pneumoniae strains, confer
low to moderate level (8-64 µg/mL) polymyxin resistance
(Miller et al., 2011).
A recent paper by Farzana et al. (2020) on isolates from
Bangladesh describes the presence of mcr-8.1 on plasmid
IncFIB(pQil) and is associated with a fitness cost. The study
proposed that mcr-8.1 inserted at the same site as carbapenem
resistance genes in IncFIB(pQil) (Farzana et al., 2020). This
paper also noted that there was evidence suggesting that
IS903B elements mediated the initial insertion of mcr-8.1 into
the IncFIB(pQil) plasmid as these were seen to bracket all
antimicrobial resistance elements in the studied strains (Farzana
et al., 2020). IS903B has also been observed in other previously
conducted studies on the mcr-8.1 carriage in K. pneumoniae
(Hadjadj et al., 2019). Interestingly, isolates KPN-15 and KPN-
19, harbour IS903B. This suggests that IS5 family elements may
have some role in resistance gene transfer but is inconclusive
regarding mcr-8.1 transfer specifically. For both our isolates
and those in the Farzana et al. (2020) paper, the sequences
flanking the mcr-8.1 gene were examined for similarities. It was
found that the genetic organisation of the contigs containing
the mcr-8.1 gene for our strains as well as the Farzana strains
were highly similar. KPN-15/19 and the three Farzana strains
share the same genetic context in the immediate flanking
regions of mcr-8.1.
In contrast, the Farzana strains have approximately the
entire length of the mcr-8.1 harbouring plasmid in common
and KPN-15 and KNP-19 share approximately 31740 bp in
the mcr-8.1 containing contigs (data not shown). Due to
the pattern of similarities in the genetic organisation, it is
hypothesised that all of the strains share a common mcr-8.1
ancestor but are not evidence of clonal spread between Qatar
and Bangladesh. Some of the key genes observed flanking mcr-
8.1 in all the strains were copR and sasA. In previous studies
the presence of copR was also observed on a K. pneumoniae
pK19 plasmid from pig faeces and a K. pneumoniae pLH94-
8 IncFII plasmid from a human sample (Wang et al., 2018;
Hadjadj et al., 2019).
A recent study described in conference proceedings
documented the first known case of mcr-8.1 of human origin in
Saudi Arabia and concluded that the resistance phenotype was
due to not only mcr-8.1 but also the presence of mcr-1.1 (Hala
et al., 2020). This corresponds to our findings that mcr-8.1 did
not appear to be the sole source of colistin resistance and worked
in collaboration with mgrB modifications. Due to our findings of
mcr-8.1 and mcr-1.1 in human isolates in Qatar, the Saudi Arabia
findings are of concern as they indicate a rise in prevalence of
these resistance mechanisms in the region. Due to this, it is
imperative that wider screening be implemented in order to
improve the detection of mcr-8.1 and other variants in the region.
Chromosomal Modifications Linked to
Colistin Resistance
In particular, mutations in the negative PhoPQ regulator mgrB, as
well as in phoP, were the main modifications in our isolates linked
to colistin resistance. Mutations, deletions, disruptions, etc. in the
mgrB gene have been linked to high levels of colistin resistance,
particularly in K. pneumoniae. While multiple mutations were
observed in the PhoPQ and PmrAB two-component systems in
our isolates, only the phoP L26Q mutation has been implicated
in colistin resistance (Uz Zaman et al., 2018). Interestingly, the
phoP L26Q mutation was also present in previously reported mcr-
8.1 harbouring K. pneumoniae (Wang et al., 2018; Bonnin et al.,
2020; Nabti et al., 2020). This question that role of this mutation
in conferring resistance.
In a 2014 study, it was reported that mgrB genes are thought
to play a significant role in the resistance phenotype (Cannatelli
et al., 2014). A 2018 study by Pitt el al noted that mgrB
disruptions at position 74 were the most common (Pitt et al.,
2018). This disruption is also seen in our isolates KPN-9 and
KPN-10. In particular, the disruption in KPN-9 was mediated
by ISKpn26; the same IS element previously identified as the
most common driver of mutation in mgrB in K. pneumoniae
(Pitt et al., 2018). For isolate KPN-15 the mgrB gene was split
at nucleotide 118 due to an insertion element of the IS1 family.
Due to the use of short-read sequencing, the specific type of IS1
element responsible for this disruption could not be determined.
The lack of mgrB in isolate KPN-20 suggests the complete
disruption of the gene.
CONCLUSION
In this study, we show that different genetic factors play a role
in colistin resistance among isolates of K. pneumoniae from
various clinical samples in a hospital in Qatar. The primary
mechanism of colistin resistance remains via chromosomal
mutations. However, we have identifiedmcr-8.1 inK. pneumoniae
and mcr-1.1 in E. coli that harbour both mcr genes and known
chromosomal mutations, more specifically a single amino acid
change in phoP, the net contribution of which needs to be
studied further. This data is complementary to previous studies
indicating the emergence of mcr-8.1 in humans, both globally and
in the Middle East. This suggests a more widespread distribution
of the gene and the necessity for wider screening to detect its
presence in clinical centres.
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